|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | |||||
| Net earnings | |||||
| Depreciation, Depletion and Amortization | |||||
| Goodwill, Impairment Loss | |||||
| Share-based compensation expense | |||||
| Deferred income taxes | |||||
| Deferred compensation payments | |||||
| Defined benefit settlement loss | |||||
| Cost of early retirement of long-term debt | |||||
| Other, net | |||||
| Increase (Decrease) in Accounts Receivable | |||||
| Increase (Decrease) in Inventories | |||||
| Increase (Decrease) in Other Current Assets | |||||
| Increase (Decrease) in Accounts Payable, Trade | |||||
| Increase (Decrease) in Other Current Liabilities | |||||
| Cash Provided by (Used in) Operating Activity, Including Discontinued Operation, Total | |||||
| Cash flow from Investing Activities | |||||
| Payments to Acquire Productive Assets | |||||
| Proceeds from sale of Infant Care business | |||||
| Proceeds from Collection of Retained Interest in Securitized Receivables | |||||
| Payment for (Proceeds from) Other Investing Activity | |||||
| Cash Provided by (Used in) Investing Activity, Including Discontinued Operation, Total | |||||
| Cash flow from Financing Activities | |||||
| Proceeds from Long-Term Lines of Credit | |||||
| Repayments of Long-Term Lines of Credit | |||||
| Cash proceeds from the issuance of Senior Notes due 2029 | |||||
| Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less | |||||
| Cost of early retirement of long-term debt | |||||
| Debt issuance costs for Senior Notes due 2029 | |||||
| Payments for Repurchase of Common Stock | |||||
| Payments of Dividends | |||||
| Payment, Tax Withholding, Share-Based Payment Arrangement | |||||
| Proceeds from (Repayments of) Accounts Receivable Securitization | |||||
| Other, net | |||||
| Cash Provided by (Used in) Financing Activity, Including Discontinued Operation, Total | |||||
| Cash and cash equivalents, beginning | |||||
| Cash and cash equivalents, ending | |||||
| Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | |||||
| Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation, Total | |||||
| Supplemental Cash Flow Information | |||||
| Cash paid for interest, net | |||||
| Cash paid for income taxes, net | |||||
Loading...